Drug Approval | August 06, 2021
India’s gets its first bio-bank for heart failure research
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
This deal makes Meddo, one of the largest health-tech players in India
The govt has rolled out three schemes for promoting the manufacture of API
Drug formulations and biologics make impressive gains
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
The company confirms an upward revision to its 2021 Outlook, reflecting the expectation to achieve mid-teens CER sales growth
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
In addition to supporting the ongoing development of the first IND-approved product in clinical trials, the proceeds will also be used to expand the 3D printed drug product pipeline
Subscribe To Our Newsletter & Stay Updated
